Next-Generation Bioresponsive Wound Healing System

Publication ID: 24-11857693_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Bioresponsive Wound Healing System,” Published Technical Disclosure No. 24-11857693_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857693_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,693.

Summary of the Inventive Concept

A futuristic wound healing system that integrates advanced technologies such as programmable matrices, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds to revolutionize wound care.

Background and Problem Solved

The original medical sealant glue capable of promoting wound healing has limitations in adapting to dynamic wound conditions, personalizing treatment, and leveraging cutting-edge technologies. The next-generation bioresponsive wound healing system addresses these limitations by incorporating self-healing polymers, bioactive molecules, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds to provide a more effective and personalized wound healing solution.

Detailed Description of the Inventive Concept

The next-generation bioresponsive wound healing system consists of a programmable matrix that adapts to dynamic wound conditions, an AI-assisted diagnostic platform that integrates real-time wound monitoring data with machine learning algorithms to predict optimal treatment strategies, a wearable electrical stimulation device powered by a bio-harvested energy source, a nanoscale wound healing agent leveraging quantum dot technology, and a 3D-printed, implantable wound healing scaffold incorporating living cells and growth factors. These components work in tandem to stimulate tissue regeneration, enhance treatment efficacy, and reduce side effects.

Novelty and Inventive Step

The novelty of the next-generation bioresponsive wound healing system lies in its integration of advanced technologies, such as programmable matrices, AI-assisted diagnostics, electrical stimulation, quantum dot delivery, and 3D-printed scaffolds, to provide a more effective and personalized wound healing solution. The inventive step resides in the synergistic combination of these technologies to create a bioresponsive system that adapts to dynamic wound conditions and optimizes treatment outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the next-generation bioresponsive wound healing system could include the use of different types of programmable matrices, AI-assisted diagnostic platforms, electrical stimulation devices, nanoscale wound healing agents, and 3D-printed scaffolds. Variations could also include the integration of additional technologies, such as gene editing or stem cell therapy, to further enhance treatment efficacy and personalize wound care.

Potential Commercial Applications and Market

The next-generation bioresponsive wound healing system has significant commercial potential in the wound care market, which is projected to grow significantly in the coming years. The system's ability to provide personalized, effective, and efficient wound healing solutions could revolutionize the industry and address the growing need for advanced wound care technologies.

CPC Classifications

SectionClassGroup
A A61 A61L24/043
A A61 A61K35/28
A A61 A61L24/0005

Original Patent Information

Patent NumberUS 11,857,693
TitleMedical sealant glue capable of promoting wound healing and preparation method thereof
Assignee(s)Shandong Branden Medical Device Co.,Ltd